Is NBRFF or MRK a better dividend investment in 2026?

NBRFF currently yields 1155.40% with a 5% 5-year dividend growth rate. MRK yields 3.25% with 8.2% growth. The better choice depends on your goal: NBRFF offers higher current income.

What is the dividend yield difference between NBRFF and MRK?

NBRFF has a forward dividend yield of 1155.40% ($2.00/share annually). MRK yields 3.25% ($3.08/share annually). The yield gap is 1152.15 percentage points.

Home › Compare › NBRFF vs MRK

NBRFF vs MRK: Dividend Comparison 2026

NBRFF yields 1155.40% · MRK yields 3.25%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 NBRFF wins by $67130800.43M in total portfolio value

INVESTMENT

TIME HORIZON10 years

NBRFF

● Live price

1155.40%

Share price

$0.17

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$67130800.46M

Annual income

$57,364,154,477,966.59

Full NBRFF calculator →

MRK

Merck & Co. Inc.

● Live price

3.25%

Share price

$94.80

Annual div

$3.08

5Y div CAGR

8.2%

Payout ratio

42%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$950.29

Full MRK calculator →

Portfolio growth — NBRFF vs MRK

📍 NBRFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	NBRFF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, NBRFF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

NBRFF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NBRFF

Annual income on $10K today (after 15% tax)

$98,209.13/yr

After 10yr DRIP, annual income (after tax)

$48,759,531,306,271.60/yr

MRK

Annual income on $10K today (after 15% tax)

$276.16/yr

After 10yr DRIP, annual income (after tax)

$807.75/yr

At 15% tax rate, NBRFF beats the other by $48,759,531,305,463.85/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NBRFF + MRK for your $10,000?

NBRFF: 50%MRK: 50%

100% MRK50/50100% NBRFF

Portfolio after 10yr

$33565400.24M

Annual income

$28,682,077,239,458.45/yr

Blended yield

85.45%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

NBRFF

No analyst data

Altman Z

22.4

Piotroski

2/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+35.6% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NBRFF buys

MRK buys

No recent congressional trades found for NBRFF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricNBRFFMRK

Forward yield	1155.40% ✓	3.25%
Annual dividend / share	$2.00	$3.08 ✓
Payout ratio	50%	42% ✓
1-year div growth	0%	5.5% ✓
5-year div CAGR	0%	8.2% ✓
Portfolio after 10y	$67130800.46M ✓	$30.7K
Annual income after 10y	$57,364,154,477,966.59 ✓	$950.29
Total dividends collected	$66398704.48M ✓	$6.1K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: NBRFF vs MRK ($10,000, DRIP)

Year	NBRFF Portfolio	NBRFF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$126,240	$115,540.15	$11,192	$351.54	+$115.0K → NBRFF
2	$1,498,236	$1,363,159.43	$12,524	$392.70	+$1.49M → NBRFF
3	$16,722,901	$15,119,788.43	$14,015	$438.65	+$16.71M → NBRFF
4	$175,615,849	$157,722,344.16	$15,682	$489.96	+$175.60M → NBRFF
5	$1,735,875,337	$1,547,966,378.71	$17,547	$547.23	+$1735.86M → NBRFF
6	$16,157,272,508	$14,299,885,897.21	$19,632	$611.16	+$16157.25M → NBRFF
7	$141,681,960,306	$124,393,678,722.99	$21,963	$682.53	+$141681.94M → NBRFF
8	$1,171,038,221,043	$1,019,438,523,515.76	$24,571	$762.18	+$1171038.20M → NBRFF
9	$9,127,706,522,638	$7,874,695,626,121.35	$27,486	$851.08	+$9127706.50M → NBRFF
10	$67,130,800,457,189	$57,364,154,477,966.59	$30,745	$950.29	+$67130800.43M → NBRFF

NBRFF vs MRK: Complete Analysis 2026

NBRFF — Stock

Carlton Precious is a publicly traded precious and base metals exploration company listed on the TSX Venture Exchange. The Company is managed by a team of experienced mining and geological professionals. Carlton Precious' projects are focused on key mining jurisdictions including Peru and Australia (central Victoria and Tasmania).

Full NBRFF Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →

📬

Get this NBRFF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NBRFF vs SCHD NBRFF vs JEPI NBRFF vs O NBRFF vs KO NBRFF vs MAIN NBRFF vs JNJ NBRFF vs ABBV NBRFF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.